Trials / Completed
CompletedNCT04179552
PAAG-OA Treatment for Knee Osteoarthritis
Prospective, Open-label Clinical Investigation of Intra-articular Polyacrylamide Hydrogel Injection in Subjects With Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Contura · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-centre, prospective, open-label, uncontrolled, clinical investigation followed by an open-label extension clinical investigation to evaluate PAAG-OA in patients with knee osteoarthritis.
Detailed description
This is a multi-centre, prospective, open-label clinical trial consisting of a main study followed by an extension study. The study will evaluate the effectiveness and safety of intra-articular polyacrylamide hydrogel (PAAG-OA) in subjects with knee OA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PAAG-OA | Intra-articular injection with PAAG-OA (polyacrylamide hydrogel) |
Timeline
- Start date
- 2019-08-21
- Primary completion
- 2020-02-07
- Completion
- 2024-09-19
- First posted
- 2019-11-27
- Last updated
- 2024-11-26
Locations
3 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04179552. Inclusion in this directory is not an endorsement.